The goal of this study is to increase production of astaxanthin in recombinant Escherichia coli by engineered isoprenoid pathway. We have previously reported structural and functional analysis of the astaxanthin biosynthesis genes from a marine bacterium, Paracoccus haeundaensis. The carotenoid biosynthesis gene cluster involved in astaxanthin production contained six carotenogenic genes (crtW, crtZ, crtY, crtI, crtB, and crtE genes) and recombinant E. coli harboring six carotenogenic genes from P. haeundaensis produced 400 μg/g dry cell weight (DCW) of astaxanthin. In order to increase production of astaxanthin in recombinant E. coli, we have cloned 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (lytB), farnesyl diphosphate (FPP) synthase (ispA), and isopentenyl (IPP) diphossphate isomerase (idi) in the isoprenoid pathway from E. coli and coexpressed these genes in recombinant E. coli harboring the astaxanthin biosynthesis genes. This engineered E. coli strain containing both isoprenoid pathway gene and astaxanthin biosynthesis gene cluster produced 1,200 μg/g DCW of astaxanthin, resulting 3-fold increased production of astaxanthin. [14] . Even though synthetically produced astaxanthin has some drawbacks to apply commercial application, it is used for both direct and indirect food additives and coloring because naturally purified astaxanthin is very limited. In cosmetology and pharmacology, it is most demanding pigments for use as a dermal photoprotector. Astaxanthin is a pigment of high economic value and various study were carried out to increased the production of astaxanthin with the application of metabolic pathway engineering [1, 18, 25, 28, 31] .
Carotenoids are natural lipid-soluble pigments produced primarily from bacteria, algae, and plants. Carotenoids have recently attracted as their beneficial effects on human health such as functions of antioxidants [23, 24] , an involvement in cancer prevention [3, 8, 13] and enhancers of immune responses [2, 5, 10] .
Astaxanthin is a carotenoid widely distributed in nature including marine animal tissues such as the red seabream, salmon, and lobster [6, 11] . Organisms that produce astaxanthin include the basidiomycetous yeast Phaffia rhodozyma [21] , the green alga Haematococcus pluvialis [4] , the Gram negative bacteria Agrobacterium aurantiacum [34] , Paracoccus marcusii [9] , Paracoccus carotinifaciens [30] , Paracoccus sp.
MBIC1143 [22] , and Paracoccus haeundaensis [14] . Even though synthetically produced astaxanthin has some drawbacks to apply commercial application, it is used for both direct and indirect food additives and coloring because naturally purified astaxanthin is very limited. In cosmetology and pharmacology, it is most demanding pigments for use as a dermal photoprotector. Astaxanthin is a pigment of high economic value and various study were carried out to increased the production of astaxanthin with the application of metabolic pathway engineering [1, 18, 25, 28, 31] .
In a previous study, we isolated and characterized a marine bacterium, Paracoccus haeundaensis, which produces astaxanthin [14] . In addition, we reported the structural and functional analysis of genes encoding the astaxanthin biosynthetic enzymes; GGPP synthase (CrtE), phytoene synthase (CrtB), phytoene desaturase (CrtI), lycopene cyclase (CrtY), ß-carotene hydroxylase (CrtZ), and ß-carotene ketolase (CrtW) [15] . The individual gene of the carotenoid biosynthesis gene cluster was functionally expressed in E. coli and each gene product was purified to homogeneity. Their molecular characteristics, including enzymatic activities, were reported [16] . Furthermore, we have reported the pathways and the functions of the astaxanthin biosynthesis genes through chromatographic and spectroscopic analyses of the pigments accumulated in E. coli carrying plasmids constructed by various combinations of the carotenoid biosynthesis genes from the P. haeundaensis [17] . The astaxanthin biosynthesis pathway is summarized in Fig. 1 .
Enhanced production of astaxanthin in engineered microbial hosts requires optimization of the available precursors pool of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), and balancing the expression Table 1 . Oligonucleotides used in this study
Name
Nucleotide sequence Remarks of carotenogenic genes for the efficient transformation of the precursors to the desired carotenoid compounds [33] . There are two isoprenoid pathways for the synthesis of IPP; the mevalonate pathway and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway [26] . Many enzymes in the isoprenoid pathways have been identified, cloned, and structurally elucidated [19, 27, 29, 32] . Even though the E. coli used for the most common hosts in metabolic engineering of the carotenoids production, it has limited supply of the common precursors such as IPP, DMAPP and FPP, because the need for such compounds for growth is relatively small [33] . Therefore, It is essential to develop the E. coli strains producing efficient and increased supply of the common precursors. The 4-Hydroxy-3-methylbut-2-enyl diphosphate reductase (encoded by lytB) catalyses the conversion of 4-Hydroxy-3-methylbut-2-enyl diphosphate into IPP and DMAPP [20] . Once IPP is formed, it is isomerized to DMAPP through IPP isomerase (coded by idi), which, upon successive addition of IPP, leads to FPP through FPP synthase (coded by ispA) as described in Fig. 1 [7] .
In the present study, in order to increase the production of the common precursors; IPP, DMAPP and FPP, we have reconstructed the isoprenoid pathway between 1-hydroy-2- C in LB medium containing tetracycline (100 μg/ml) and kanamycine (50 μg/ml).
In order to construct the expression plasmid for the lytB gene (GenBank Access No. NC_002655) from E. coli, PCR was carried out using a pair of oligonucleotides with lytB-F and lytB-R primers (Table 1 ) and E. coli genomic DNA as a template, and the PCR product was ligated into pGEM-T-easy vector (Promega, USA). The resulting plasmid, pGEM-T-easy-lytB, was partial digested with both NdeI and XbaI enzymes. Then, the excised fragment was ligated into pHCE IIB plasmid (NdeI) (Takara, Japan) with a constitutive HCE promoter of Geobacillus toebii and resulted in as pHCE IIB-lytB plasmid (Fig. 2) . In the next step, PCR was performed using a pair of oligonucleotides with HCE-F and lytB-R2 primers (Table 1 ) and pHCE IIB-lytB (Fig. 2) as a template, and ligated into pGEM-T-easy vector. The resulting plasmid, pGEM-T-easy-HCE-lytB, was digested with EcoRI enzyme and ligated into pACYC184 plasmid (Novagen, USA) previously digested with EcoRI enzyme and treated with calf intestinal alkaline phosphatase (CIAP) for preventing self-ligation. The resulting plasmid, pACYC184-lytB (Fig. 2) , was transformed into E. coli BL21(DE3) Codon Plus RIL.
To construct the expression plasmid for the idi gene (GenBank Access No. CP000948) from E. coli, it was carried out that PCR using a pair of oligonucleotides with idi-F and idi-R primers (Table 1 ) and E. coli genomic DNA as a template, and the PCR product was ligated into pGEM-T-easy vector. The resulting plasmid, pGEM-T-easy-idi, was digested with both NdeI and XbaI enzymes. Then, the excised fragment was ligated into pHCE IIB(NdeI) with constitutive HCE promoter and resulted in as pHCE IIB-idi plasmid (Fig.  2) . In the next step, PCR was performed using a pair of oligonucleotides with HCE-F and idi-R2 primers (Table 1) and pHCE IB-idi (Fig. 2) as a template, and ligated into pGEM-T-easy vector. The resulting plasmid, pGEM-T-easy-HCE-idi, was digested with EcoRI enzyme and ligated into pACYC184 plasmid previously digested with EcoRI enzyme and treated with calf intestinal alkaline phosphatase (CIAP) for preventing self-ligation. The resulting plasmid, pACYC184-idi ( Fig.   2 ), was transformed into E. coli BL21(DE3) Codon Plus RIL. In order to construct the expression plasmid for the ispA gene (GenBank Access No. D00694) from E. coli, it was carried out that PCR using a pair of oligonucleotides with ispA-F and ispA-R primers (Table 1 ) and E. coli genomic DNA as a template, and the PCR product was ligated into pGEM-T-easy vector. The resulting plasmid, pGEM-T-easyispA, was digested with both NdeI and XbaI enzymes. Then, the excised fragment was ligated into pHCE IIB(NdeI) with constitutive HCE promoter and resulted in as pHCE IIB-ispA plasmid (Fig. 2) . In the next step, PCR was performed using a pair of oligonucleotides with HCE-F and ispA-R2 primers (Table 1 ) and pHCE IIB-ispA (Fig. 2) as a template, and ligated into pGEM-T-easy vector. The resulting plasmid, pGEM-T-easy-HCE-ispA, was digested with EcoRI enzyme and ligated into pACYC184 plasmid previously digested with EcoRI enzyme and treated with calf intestinal alkaline phosphatase (CIAP) for preventing self-ligation. The resulting plasmid, pACYC184-ispA (Fig. 2) , was transformed into E. coli BL21(DE3) codon plus. In a previous study, we constructed pCR-XL-TOPO-Crt-full plasmid carrying the full-length astaxanthin biosynthesis gene cluster [15] . The pCR-XL-TOPO-Crt-full plasmid and pACYC184-lytB, pACYC184-idi, and pACYC184-ispA plasmid, respectively were transformed into E. coli BL21(DE3) Codon Plus RIL.
Ten grams of the lyophilized cells of E. coli BL21(DE3) Codon Plus RIL carrying a plasmid were resuspended in 10 ml acetone and incubated over night at 4 o C. Acetone was evaporated and the pellet was dissolved in 10 mL of n-hexane-ethanol (1:1, v/v). Then, the extract was diluted to 1/2 with distilled water, and two phases were separated with a separatory funnel. Organic phase (n-hexane phase) was washed with 30% aqueous ethanol until colorless and near neutral pH. After separation, the organic phase was blown to dryness under a stream of nitrogen, and then, the residue was stored in a refrigerator.
The astaxanthin extract was dissolved in 2-propanol and subjected onto high-performance liquid chromatography (HPLC). Chromatography was performed using an Agilent 1100 HPLC system equipped with a temperature-controlled autosampler and a diode array detector. The column was a YMC carotenoid C30 colum (5 micron, steel, 250 mm To calculate the amount of the accumulated astaxanthin from the transformed cells, the following equation was used [12] .
Total carotenoid (g) = ml of solvent × Aλmax
The specific absorbance coefficient, A   (= specific extinction coefficient, E   ), where representing the absorbance of 1% (w/v) solution (1 g/100 ml) in a 1-cm path cuvette at the appropriate wavelength, was applied for the determination of the concentrations of astaxanthin.
As shown in Figure 1 , the lytB, idi, and ispA genes in the isoprenoid pathway are essential for biosynthesis of IPP, DMAPP and FPP. Theses precursors are crucial compounds for the efficient production of astaxanthin from FPP. However, E. coli cell has limited supply of these common precursors because E. coli cell itself needs only small amount of such compounds for growth. In the present study, the lytB, idi, and ispA genes from E. coli were cloned and introduced into separate E. coli strains for comparisons of the common precursors. The results showed the efficient production of IPP, DMAPP and FPP. In order to increase production of astaxanthin, we have used these strains for co-expression of both the astaxanthin biosynthesis gene cluster (pCR-XL-TOPO-Crt-full containing crtW, crtZ, crtY, crtI, crtB, and crtE genes) from P. haeundaensis and the lytB, idi, and ispA genes in the isoprenoid pathway.
The plate of the cells transformed with pCR-XL-TOPOCrt-full and pACYC184-lytB plasmid was shown in a red color, indicating that the expressed proteins; LytB, CrtE, CrtB, CrtI, CrtY, CrtZ, and CrtW, mediate the formation of a red colored astaxanthin through metabolic intermediates; zeaxanthin, β-carotene, lycopene, phytoene, GGPP, FPP, IPP, and DMAPP from 4-Hydroxy-3-methylbut-2-enyl diphosphate as summarized in Fig. 1 . In order to calculate the amount of the accumulated carotenoids from the transformed cells, the equation (1) Crt-full and pACYC184-ispA plasmid was shown in a red color, indicating that the expressed proteins, IspA, CrtE, CrtB, CrtI, CrtY, CrtZ, and CrtW, mediate the formation of a red colored astaxanthin via zeaxanthin, β-carotene, lycopene, phytoene, GGPP, and FPP from IPP and DMAPP. The amounts of astaxanthin, zeaxanthin, and β-carotene using the formula (1) were calculated to 650 μg/g DCW, 290 μg/g Fig. 3 . Time profiles of cell growth and astaxanthin production (μg/g DCW). BL21(DE3) Codon Plus RIL was used as the host strain with the pCR-XL-TOPO-Crt-full and pACYC184-idi plasmids that lead to astaxanthin production. (□), cell growth; (■), astaxanthin in LB medium.
DCW, and 120 μg/g DCW DCW, respectively. The accumulated amount of produced astaxanthin of these strains are summarized in Table 2 .
We have previously reported the expression of the astaxanthin biosynthesis gene cluster (pCR-XL-TOPO-Crt-full containing crtW, crtZ, crtY, crtI, crtB, and crtE genes) from P. haeundaensis in E. coli BL21(DE3) Codon Plus RIL [15] .
With comparisons of produced astaxanthin contents from those data with this study, the amounts of accumulated astaxanthin by the co-expression system of both the lytB, idi, and ispA genes in the isoprenoid pathway and the astaxanthin biosynthesis gene cluster (pCR-XL-TOPO-Crt-full containing crtW, crtZ, crtY, crtI, crtB, and crtE genes) have higher values than those of the expression system using only astaxanthin biosynthesis genes. This engineered E. coli strain containing both isoprenoid pathway genes and astaxanthin biosynthesis gene cluster (both pCR-XL-TOPO-Crt-full and pACYC184-idi plasmid) produced 1200 μg/g DCW of astaxanthin, resulting 3-folds increased production of astaxanthin compared to the E. coli transformant harboring only pCR-XL-TOPO-Crt-full plasmid. Growth patterns and astaxanthin production from recombinant E. coli cells harboring pCR-XL-TOPO-Crt-full and pACYC184-idi plasmid were shown in Fig. 3 . The recombinant E. coli strains were grown in batch culture for 50 hr with shaking in LB medium containing tetracycline (100 μg /ml) and kanamycine (50 μg/ml) at 37 o C. The production of astaxanthin reached a plateau after 30 hr incubation. In the present study, we have achieved the enhanced production of astaxanthin by the co-expression system using the combinational constructs of the carotenoid biosynthesis genes from P. haeundaensis and isoprenoid biosynthesis genes from E. coli. Consequently, the results of this study can be used to enhance the production of astaxanthin through the manipulation of carotenoid biosynthesis genes in P. haeundaensis and isoprenoid biosynthesis genes from E. coli, and an important application since astaxanthin is a pigment of high economic value. These data will provide a wider base of knowledge on the gene expression of the astaxanthin biosynthesis gene cluster at the molecular level as well as further the biotechnological applications of carotenoids. Moreover, the possibility to control separately the expression levels of the lytB, idi, and ispA genes in E.
coli will provide us with wider applications of the E. coli co-expression system.
